Pedro Luis
Sánchez Fernández
Catedrático de Universidad
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (11)
2024
2023
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity
Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143
2020
-
Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy
Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269
2019
-
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity
Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791
2017
-
Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage
Circulation, Vol. 136, Núm. 14, pp. 1288-1300
-
Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction
Circulation Research, Vol. 121, Núm. 4, pp. 439-450
2016
-
Data from acellular human heart matrix
Data in Brief
2015
-
Acellular human heart matrix: A critical step toward whole heart grafts
Biomaterials, Vol. 61, pp. 279-289